BNT vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive assessment of bankruptcy risk. Valuation metrics suggest the stock is trading below its Graham Number of $70.03 and significantly below the intrinsic value estimate of $121.54, implying potential undervaluation. However, weak revenue growth, limited analyst coverage, and a bearish technical trend temper optimism. The strong operating margin and low debt/equity ratio support stability, but lackluster top-line growth and minimal dividend yield constrain appeal.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BNT vs BRK-B: Head-to-Head Comparison
This page compares Brookfield Wealth Solutions Ltd. (BNT) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.